BE543567A - - Google Patents

Info

Publication number
BE543567A
BE543567A BE543567DA BE543567A BE 543567 A BE543567 A BE 543567A BE 543567D A BE543567D A BE 543567DA BE 543567 A BE543567 A BE 543567A
Authority
BE
Belgium
Prior art keywords
piperazine
pyridoxine
compositions
therapeutic composition
hydrochloride
Prior art date
Application number
Other languages
English (en)
French (fr)
Publication of BE543567A publication Critical patent/BE543567A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BE543567D BE543567A (de)

Publications (1)

Publication Number Publication Date
BE543567A true BE543567A (de)

Family

ID=171838

Family Applications (1)

Application Number Title Priority Date Filing Date
BE543567D BE543567A (de)

Country Status (1)

Country Link
BE (1) BE543567A (de)

Similar Documents

Publication Publication Date Title
EP0233853B1 (de) Brausepaare, H2-Antagonisten von Histamin enthaltende Brausemischungen und Verfahren zu ihrer Herstellung
FR2631232A1 (fr) Adsorbats medicamenteux
BE1005691A4 (fr) Composition pharmaceutique a base de ranitidine et son procede de preparation.
EP1108424B2 (de) Trimetazidinhaltige Matrixtablette zur verlängerten Wirkstofffreisetzung nach oraler Gabe
EP0914124B1 (de) Antithrombotische antiatherosklerotische pharmazeutische zusammensetzung aus einem thienopyridinderivat und einem hmg-coa-reduktase-hemmer
EP1178809A1 (de) Acetylsalicylsaüre und clopidogrel hydrogenosulfat enthaltende pharmazeutische zusammensetzung in einzeldosisform
CA2123232C (fr) Compositions pharmaceutiques a base d'ebastine ou de ses analogues
FR2666508A1 (fr) Compositions pharmaceutiques contenant des derives de furanne.
JPH01193224A (ja) モクソニジンを含有する製薬学的組成物及びその製造法
BE543567A (de)
FR2604902A1 (fr) Compositions pharmaceutiques a liberation prolongee
EP0412901B1 (de) Verwendung von Trifluormethylphenyltetrahydropyridinen zur Herstellung von Arzneimitteln zur Bekämpfung intestinaler Motilitätsstörungen
BE1004182A3 (fr) Compositions pharmaceutiques contenant un compose a activite agoniste selective aux recepteurs analogues a la 5-ht1.
WO1999025363A1 (fr) Association de principes actifs, notamment de tetrahydropyridines et d'agents inhibiteurs de l'acetylcholinesterase, pour le traitement de la demence senile du type alzheimer
EP1358159B1 (de) Tartrat- und phosphatsalz von 3,4-diaminopyridin, pharmazeutische zusammensetzung und deren verwendung
FR2525900A1 (fr) Compositions therapeutiques a base de nouvelles argiles modifiees
FR2544614A1 (fr) Nouvelle association medicamenteuse pour le traitement de l'hypertension
BE1003959A5 (fr) Agent therapeutique pour le traitement de troubles associes a l'ischemie cerebrale.
EP0950050B1 (de) Verfahren zur kristallisierung eines tetrahydropyridinderivates und die so erhaltenen kristallinen formen
EP0412877A1 (de) Orale Arzneiform zur Verbesserung der Bioverfügbarkeit
FR2691630A1 (fr) Composition pharmaceutique, en particulier pour l'administration orale, contenant, comme ingrédient actif, un agoniste sélectif des récepteurs de type 5HT1.
FR2648710A1 (fr) Composition pharmaceutique a base de ranitidine et son procede de preparation
WO2013114416A1 (en) Lyophilized tablets of escitalopram oxalate for sublingual administration
CH660189A5 (fr) Sels de dioxyde de benzothiazine cristallin et compositions pharmaceutiques les contenant.
FR2464071A1 (fr) Preparation pharmaceutique a base de dihydro-ergotamine et d'heptaminol